CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Menorrhagia (heavy menstrual bleeding) - Management
When should I prescribe pharmaceutical treatment in women presenting with menorrhagia?
- Pharmaceutical treatment is recommended first-line for woman with menorrhagia who:
- Have no symptoms suggestive of underlying pathology including postcoital bleeding, intermenstrual bleeding, dyspareunia, dysmenorrhoea, vaginal discharge, and pelvic pain and/or pressure (these symptoms may indicate pelvic inflammatory disease, endometriosis, or endometrial carcinoma). See History.
- Are awaiting the results of investigations.
© NHS Institute for Innovation and Improvement